Here are three things to know:
1. The company uses autologous bioactive cells in a range of clinical applications.
2. Royal Biologics’ Maxx-Cell is a bone marrow extraction device that does not require centrifugation. It is designed to maximize cell count yields while minimizing peripheral blood dilution.
3. Demetri Soteropoulos and Salvatore Leo co-founded Royal Biologics in 2015. Mr. Soteropoulus serves as chairman, and Mr. Leo is the CEO. Combined they have 30 years of medical device company experience.
More articles on biologics:
FDA to crackdown on ‘bogus’ stem cell treatments in 2019
Axolotl Biologix launches new regenerative fluid syringe for orthopedic wound care: 3 details
Center for Neurosciences, Orthopaedics & Spine using plasma injections to treat joint pain
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
